Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia-Reference-Cited by-同舟云学术

Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia

Published:2012-03 Issue:3 Volume:40 Page:216-227
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Linden Michael A.,Kirchhof Nicole,Carlson Cathy S.,Van Ness Brian G.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference36 articles.

1. Multiple myeloma;Raab;Lancet,2009

2. Signaling mechanisms through gp130: a model of the cytokine system;Hirano;Cytokine Growth Factor Rev,1997

3. Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial;Liu;Blood,1996

4. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis;Bezieau;Hum Mutat,2001

5. Clinical and biological significance of RAS mutations in multiple myeloma;Chng;Leukemia,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma;Frontiers in Immunology;2021-06-02

2. The Effect of Resveratrol on Cell Viability in the Burkitt’s Lymphoma Cell Line Ramos;Molecules;2017-12-21

3. KSHV Latency Locus Cooperates with Myc to Drive Lymphoma in Mice;PLOS Pathogens;2015-09-01

4. Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy;Blood;2014-01-30